Internal Medicine, Pulmonary Disease · Minneapolis, MN
NPI
1891885307
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
9
Medicare group memberships
Hospitals
3
Hospital affiliations
516 Delaware St SE, Pwb 2nd Floor, Clinic 2a
Minneapolis, MN, 55455
Phone (612) 626-6100
Groups this clinician bills Medicare through
Medicare paid, 2024
$110K
3,176 services
Medicare patients, 2024
996
Average age 70
Drug cost, 2024
$3.3M
1,158 prescriptions
Company payments, 2025
$175
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hyun Joo Kim was code 94375 (pulmonary function testing), 750 times for 645 patients. In total Hyun Joo Kim billed 3,176 services in 33 codes, and Medicare paid $110K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-03-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 94375 Pulmonary Function Testing | Office | 750 | 645 | $28.88 | $22K |
| 94729 Pulmonary Function Testing | Office | 749 | 684 | $39.61 | $30K |
| 94726 Pulmonary Function Testing | Office | 625 | 583 | $39.22 | $25K |
| 94618 Pulmonary Function Testing | Office | 262 | 240 | $24.78 | $6,492 |
| 94060 Pulmonary Function Testing | Office | 146 | 145 | $25.21 | $3,680 |
| 99215 Office E&M - Established | Facility | 99 | 52 | $99.86 | $9,886 |
| 94729 Pulmonary Function Testing | Facility | 59 | 58 | $6.42 | $379 |
| 94726 Pulmonary Function Testing | Facility | 58 | 57 | $8.69 | $504 |
| 99214 Office E&M - Established | Facility | 54 | 45 | $64.77 | $3,497 |
| 94640 Treatment - Miscellaneous | Office | 48 | 28 | $5.96 | $286 |
| 94642 Treatment - Miscellaneous | Office | 46 | 26 | $21.76 | $1,001 |
| J2545 Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg | Office | 45 | 26 | $58.03 | $2,611 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 36 | 18 | $21.63 | $779 |
| 94375 Pulmonary Function Testing | Facility | 33 | 26 | $10.48 | $346 |
| 94010 Pulmonary Function Testing | Facility | 33 | 32 | $5.95 | $196 |
By year: 2022 $102K for 2,775 services; 2023 $102K for 2,919 services; 2024 $110K for 3,176 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36600 General Laboratory | 14 | 14 | $20.53 | $287 |
Medicare prescription drug claims, 2024
In 2024, the drug Hyun Joo Kim prescribed most often to Medicare patients was Ofev (Nintedanib Esylate), with 215 prescriptions and refills. In total Hyun Joo Kim wrote 1,158 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ofev Nintedanib Esylate | 215 | 221 | 28 | $2.7M |
| Prednisone Generic | 111 | 250 | 31 | $860 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 105 | 202 | 26 | $971 |
| Mycophenolate Mofetil Generic | 93 | 181 | 23 | $9,426 |
| Pirfenidone Generic | 81 | 81 | Under 11 | $136K |
| Azithromycin Generic | 80 | 129 | 20 | $2,220 |
| Breo Ellipta Fluticasone/Vilanterol | 53 | 71 | 15 | $26K |
| Incruse Ellipta Umeclidinium Bromide | 35 | 46 | Under 11 | $16K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 31 | 41 | Under 11 | $7,515 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 30 | 37 | 14 | $1,366 |
| Omeprazole Generic | 28 | 66 | Under 11 | $475 |
| Montelukast Sodium Generic | 28 | 72 | Under 11 | $311 |
| Thalomid Thalidomide | 22 | 22 | Under 11 | $140K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 22 | 30 | Under 11 | $18K |
| Fluticasone Propionate Generic | 22 | 50 | Under 11 | $280 |
Brand drugs: 523 claims; generic drugs: 635 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hyun Joo Kim $175 ($175 in general payments such as food, travel and fees) from 5 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $175.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $175 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.